Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.
A new Cochrane review confirmed that antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), are superior to placebo in ...
Credit: Getty Images. Lexapro is a selective serotonin reuptake inhibitor. The Food and Drug Administration (FDA) has approved Lexapro (escitalopram) for the treatment of generalized anxiety disorder ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage. The ...
In the treatment of mental health disorders like depression and anxiety, selective serotonin reuptake inhibitors (SSRIs) are often prescribed as first-line treatments. Among the most popular SSRIs are ...
Anxiety and depression are common but serious mental health issues that can cause a dramatic decrease in functioning and quality of life. In the United States, about 1 in 5 people experience anxiety, ...
Occasionally worrying about an upcoming work presentation, a stressful family situation, or a complicated relationship is a natural part of life. But when that worry becomes excessive, frequent, and ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage. GAD ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage. GAD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results